Tranexamic acid (TXA) protects against periprosthetic joint infections within the first 90 days following total joint arthroplasty, a study has found.
“Tranexamic acid is widely used to minimize blood loss during total joint arthroplasty,” said Lauren Wilson, MPH, a biostatistician in the anesthesiology department at the Hospital for Special Surgery, in New York City. “This reduction in blood loss and the need for blood transfusions can provide additional